ArticleRandomized controlled clinical trial of two modality treatments for refractory wound seroma after modified radical mastectomy
ArticleRandomized controlled clinical trial of two modality treatments for refractory wound seroma after modified radical mastectomy
ArticleTHE INCIDENCE OF AXILLARY LYMPH NODE INVOLVEMENT AFTER POSITIVE SENTINEL LYMPH NODE BIOPSY IN BREAST CANCER SURGERY .
ArticleTHE INCIDENCE OF AXILLARY LYMPH NODE INVOLVEMENT AFTER POSITIVE SENTINEL LYMPH NODE BIOPSY IN BREAST CANCER SURGERY .
ArticleRETROSPECTIVE STUDY TO ASSESS AXILLARY MANAGEMENT AND ONCOLOGICAL OUTCOME AFTER NEOADJUVANT CHEMOTHERAPY FOR BREAST CANCER PATIENTS
ArticleRETROSPECTIVE STUDY TO ASSESS AXILLARY MANAGEMENT AND ONCOLOGICAL OUTCOME AFTER NEOADJUVANT CHEMOTHERAPY FOR BREAST CANCER PATIENTS
ArticleAxillary Lymph Node Dissection versus Axillary Radiation in Patients with Positive Sentinel Lymph Node Biopsy in Early Breast Cancer
ArticleAxillary Lymph Node Dissection versus Axillary Radiation in Patients with Positive Sentinel Lymph Node Biopsy in Early Breast Cancer
ArticleSENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY IN CLINICALLY NODE POSITIVE AXILLA OF BREAST CANCER
ArticleSENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY IN CLINICALLY NODE POSITIVE AXILLA OF BREAST CANCER
ArticleSENTINEL LYMPH NODES DISSECTION VERSUS AXILLARY LYMPH NODES DISSECTION IN PATIENTS WITH EARLY BREAST CANCER AND SENTINEL NODES METASTASES
ArticleSENTINEL LYMPH NODES DISSECTION VERSUS AXILLARY LYMPH NODES DISSECTION IN PATIENTS WITH EARLY BREAST CANCER AND SENTINEL NODES METASTASES
ArticleThe Role of Fibrin Glue in Reducing Seroma Formation after Modified Radical Mastectomy in Patients with Breast Cancer: A Prospective Randomized Study
ArticleThe Role of Fibrin Glue in Reducing Seroma Formation after Modified Radical Mastectomy in Patients with Breast Cancer: A Prospective Randomized Study
ArticleLymph node tattooing for targeted axillary dissection in postneoadjuvant chemotherapy breast cancer
ArticleLymph node tattooing for targeted axillary dissection in postneoadjuvant chemotherapy breast cancer